Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
AMPH
$20.91
+3.62%
AMPH · Amphastar Pharmaceuticals, Inc.
$20.91
+0.73 (+3.62%)
At close · Aug 14
Market Cap
$889.47M
Shares
42.54M
All earnings calls
Earnings call · FY2024 Q2
Amphastar Pharmaceuticals, Inc. Q2 FY2024 Earnings Call
Amphastar Pharmaceuticals, Inc. Q2 FY2024 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$182.39M
+25.2% YoY
Diluted EPS
$0.73
+49% YoY
Gross margin
52.2%
+2.3 pp YoY
Net income
$37.95M
+45.3% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 7, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 9, 2024 · complete as-filed document